Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
14
|
| pubmed:dateCreated |
1996-9-5
|
| pubmed:abstractText |
BRCA1 is proposed to be a tumor suppressor gene. To explore the biological function of BRCA1, a partial deletion (amino acids 300-361) of mouse Brca1 exon 11 was introduced into the genome of embryonic stem (ES) cells by homologous recombination. Mice carrying one mutated allele of Brca1 appear normal and are fertile up to 10 months of age without any sign of illness. However, no viable progeny homozygous for the Brca1 mutant allele were obtained. Detailed analysis of large numbers of embryos at different stages of development indicated that the homozygous mutant concepti are severely retarded in growth as early as embryonic day 4.5 (E4.5) and are resorbed completely by E8.5. Although the homozygotes at E5.5-E6.5 are able to synthesize DNA and display distinguishable embryonic and extraembryonic structures, they fail to differentiate and form egg cylinders. Consequently, they were unable to form primitive streaks and undergo gastrulation. Consistent with these in vivo results, blastocysts homozygous for mutated Brca1 alleles are at a considerable disadvantage when grown in vitro. These observations suggest that Brca1 has an important role in the early development of mouse embryos.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0890-9369
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1835-43
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:8698242-Animals,
pubmed-meshheading:8698242-BRCA1 Protein,
pubmed-meshheading:8698242-Base Sequence,
pubmed-meshheading:8698242-Breast Neoplasms,
pubmed-meshheading:8698242-Crosses, Genetic,
pubmed-meshheading:8698242-Culture Techniques,
pubmed-meshheading:8698242-Embryonic and Fetal Development,
pubmed-meshheading:8698242-Female,
pubmed-meshheading:8698242-Fetal Death,
pubmed-meshheading:8698242-Gene Targeting,
pubmed-meshheading:8698242-Genes, Tumor Suppressor,
pubmed-meshheading:8698242-Germ-Line Mutation,
pubmed-meshheading:8698242-Heterozygote,
pubmed-meshheading:8698242-Homozygote,
pubmed-meshheading:8698242-Humans,
pubmed-meshheading:8698242-Male,
pubmed-meshheading:8698242-Mice,
pubmed-meshheading:8698242-Mice, Knockout,
pubmed-meshheading:8698242-Mice, Mutant Strains,
pubmed-meshheading:8698242-Molecular Sequence Data,
pubmed-meshheading:8698242-Neoplasm Proteins,
pubmed-meshheading:8698242-Oligodeoxyribonucleotides,
pubmed-meshheading:8698242-Ovarian Neoplasms,
pubmed-meshheading:8698242-Pregnancy,
pubmed-meshheading:8698242-Sequence Deletion,
pubmed-meshheading:8698242-Transcription Factors
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.
|
| pubmed:affiliation |
Center for Molecular Medicine/Institute of Biotechnology, The University of Texas Health Science Center at San Antonio 78245, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|